(Q57605852)

7

0 references

author name string

P E Morange

1

0 references

L Tiret

3

0 references

N Saut

4

0 references

G Luc

5

0 references

D Arveiler

6

0 references

A Evans

9

0 references

P Ducimetiere

10

0 references

F Cambien

11

0 references

I Juhan-Vague

European Journal of Human Genetics

12

0 references

publication date

15 September 2004

0 references

published in

0 references

volume

12

0 references

issue

12

0 references

page(s)

1041-1049

0 references

cites work

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Innate and acquired immunity in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Role of heat shock proteins in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Toll receptors, CD14, and macrophage activation and deactivation by LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

CD14: cell surface receptor and differentiation marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Toll, a new piece in the puzzle of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers: the Carotid Atherosclerosis Progression Study (CAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Soluble CD14 and aortic stiffness in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Toll-like Receptor 4 Polymorphisms and Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

7 January 2021

C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

7 January 2021

CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

7 January 2021

C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

7 January 2021

The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201277

7 January 2021